TuHURA Biosciences, Inc.
HURA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $12,657 | $3,665 | $14,253 | $5,546 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $223 | $334 | $101 | $0 |
| Inventory | $215 | $0 | $0 | $0 |
| Other Curr. Assets | $6,516 | $159 | $390 | $135 |
| Total Curr. Assets | $19,610 | $4,159 | $14,744 | $5,681 |
| Property Plant & Equip (Net) | $323 | $203 | $419 | $617 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $34 | $0 | $34 | $104 |
| Total NC Assets | $356 | $203 | $452 | $721 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $19,967 | $4,362 | $15,197 | $6,402 |
| Liabilities | – | – | – | – |
| Payables | $3,153 | $1,867 | $1,916 | $414 |
| Short-Term Debt | $160 | $21 | $117 | $644 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2,017 | $1,709 | $839 | $6,092 |
| Total Curr. Liab. | $5,330 | $3,596 | $2,872 | $7,150 |
| LT Debt | $43 | $2,324 | $21 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $43 | $2,324 | $21 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $203 | $21 | $138 | $0 |
| Total Liabilities | $5,373 | $5,921 | $2,893 | $7,150 |
| Equity | – | – | – | – |
| Pref Stock | $279 | $8 | $8 | $5 |
| Common Stock | $42 | $7 | $5 | $5 |
| Retained Earnings | -$111,125 | -$88,475 | -$59,158 | -$49,479 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $125,398 | $86,901 | $71,450 | $48,722 |
| Total Equity | $14,594 | -$1,559 | $12,304 | -$748 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $19,967 | $4,362 | $15,197 | $6,402 |
| Net Debt | -$12,455 | -$1,320 | -$14,114 | -$4,902 |